Physician profile

Randell B Minton

Cardiovascular Disease · Little Rock, AR

NPI 1548216138

$2,448.03

in general payments reported to CMS, 2019-2025

15 companies · $483 in 2025

The $483 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$792.22

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Novartis Pharmaceuticals Corporation $857.88 2019-2025
Shockwave Medical, INC $472.04 2021-2025 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Boston Scientific Corporation $333.13 2019-2024 Rotapro, Opticross, Avvigo Guidance System
Abiomed $257.88 2019-2022
Abbott Laboratories $212.97 2021-2025 Cardiomems, Mitraclip
E.R. Squibb & Sons, L.L.C. $84.22 2024-2025 Camzyos
Baxter Healthcare $55.55 2024 Hillrom - Carnation Ambulatory Monitor
Amgen INC. $37.49 2019-2020
Irhythm Technologies, INC. $36.18 2024 Zio Xt Patch, Zio Monitor
Cvrx, INC. $20.68 2025 Barostim Neo System
Edwards Lifesciences Corporation $19.00 2023 Edwards Sapien 3 Ultra Transcatheter Heart Valve
Cardiva Medical, INC. $17.48 2025 Cardiva Vascade 6/7f Vcs
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $16.67 2022
Actelion Pharmaceuticals US, INC. $14.73 2021
Janssen Pharmaceuticals, INC $12.13 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Randell B Minton

$2,448.03

in general payments reported 2019-2025

Years
2019-2025
Top company
Novartis Pharmaceuticals Corporation
Context
The $483 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/720365/randell-b-minton

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.